Looking for a biopharma job in Boston? Check out the BioSpace list of nine companies hiring life sciences professionals like ...
A rapturous response to data published last year for Pelage’s hair loss candidate overwhelmed the biotech. Now, the company ...
Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI, but drug discovery is not the primary success story—yet.
This webinar provides a clear-eyed assessment of current hiring conditions across biopharma, exploring which roles and skills ...
The newly public Evommune shared data showing that EVO301, an IL-18 targeting protein, cleared symptoms comparably to Regeneron and Sanofi’s mega-blockbuster in a mid-stage atopic dermatitis clinical ...
The agency flagged several violations at a compounding pharmacy owned by Hims & Hers, including “infestation by rodents, ...
Kailera will launch a global Phase 2 study of ribupatide this year, while Hengrui will push the asset into Phase 3 in China.
The FDA recommended that REGENXBIO run a new study, treat more patients and include a placebo arm to support a resubmission ...
Novo Nordisk has sued Hims for allegedly violating patents protecting semaglutide, seeking potentially “hundreds of millions” ...
AstraZeneca will push the pill, elecoglipron, into a comprehensive late-stage program that will test the drug as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results